inolimomab inolimomab inolimomab is a mouse monoclonal antibody developed as an immunosuppressive drug against graft-versus-host disease. its target is the alpha chain of the interleukin-2 receptor. inolimomabmonoclonal antibodytypewhole antibodysourcemousetargetcd25clinical dataatc codenoneidentifierscas number152981-31-2 nchemspidernoneuniigo90dfk14u ny (what is this?) (verify)